259 filings
Page 5 of 13
8-K
sv5zp5p
24 Feb 21
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
6:46am
D
idvx9in2
15 Jan 21
$649.99M in equity, sold $649.99M, 1 investor
4:06pm
8-K
bda l62x8
7 Jan 21
Sage Therapeutics Provides 2021 Corporate Strategy Update at J.P. Morgan Healthcare Conference
4:14pm
8-K
qfaei8vd lgnxuv
31 Dec 20
Other Events
4:05pm
8-K
uhbrabk bkh689vq
16 Dec 20
Departure of Directors or Certain Officers
7:00am
8-K
7kt2nlw
27 Nov 20
Entry into a Material Definitive Agreement
7:38am
8-K
izmf4tphnnlkt 0l
5 Nov 20
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
p2yiidhj53
15 Oct 20
Sage Therapeutics Announces Positive Interim, Topline Zuranolone
9:14am
8-K
6e59thace60 r9k5av
1 Oct 20
Sage Therapeutics Appoints Barry Greene to Board of Directors
4:05pm
UPLOAD
tz7mt
1 Sep 20
Letter from SEC
12:00am
CORRESP
pwfbpj639ghxsyt unhj
20 Aug 20
Correspondence with SEC
12:00am
8-K
ny7rio
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
CORRESP
8t4qcugy85w8zexom 1x
3 Aug 20
Correspondence with SEC
12:00am
UPLOAD
cw1do9h02
23 Jul 20
Letter from SEC
12:00am
8-K
kfll4
10 Jun 20
Submission of Matters to a Vote of Security Holders
4:06pm
CT ORDER
uadl jt0kz87
29 May 20
Confidential treatment order
2:32pm
8-K
mf692flkzzruyhz96
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm